Susquehanna International Group’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $162K | Sell |
|
|||||
|
2025
Q2 | $442K | Sell |
|
|||||
|
2025
Q1 | $2.2M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $72.2K | Sell |
|
|||||
|
2024
Q2 | $185K | Buy |
|
|||||
|
2024
Q1 | $95.9K | Sell |
|
|||||
|
2023
Q4 | $184K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $31.7K | Buy |
|
|||||
|
2023
Q1 | – | Hold |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $231K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $13K | Sell |
|
|||||
|
2021
Q4 | $68K | Sell |
|
|||||
|
2021
Q3 | $334K | Sell |
|
|||||
|
2021
Q2 | $541K | Buy |
|
|||||
|
2021
Q1 | $909K | Buy |
|
|||||
|
2020
Q4 | $202K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Hold |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $6K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $46K | Sell |
|
|||||
|
2018
Q4 | $40K | Buy |
|
|||||
|
2018
Q3 | $77K | Buy |
|
|||||
|
2018
Q2 | $13K | Sell |
|
|||||
|
2018
Q1 | $60K | Buy |
|
|||||
|
2017
Q4 | $17K | Buy |
|
|||||
|
2017
Q3 | $12K | Sell |
|
|||||
|
2017
Q2 | $65K | Buy |
|
|||||
|
2017
Q1 | $95K | Buy |
|
|||||
|
2016
Q4 | $17K | Buy |
|
|||||
|
2016
Q3 | $6K | Buy |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $15K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $28K | Sell |
|
|||||
|
2014
Q4 | $107K | Sell |
|
|||||
|
2014
Q3 | $237K | Sell |
|
|||||
|
2014
Q2 | $636K | Sell |
|
|||||
|
2014
Q1 | $847K | Sell |
|
|||||
|
2013
Q4 | $1.02M | Buy |
|
|||||
|
2013
Q3 | $1.16M | Buy |
|
|||||
|
2013
Q2 | – | Hold |
|